MARA:NASDAQMARA Holdings, Inc. Analysis
Data as of 2026-06-17 - not real-time
$13.92
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Neutral technical stance with the 20‑day SMA above the 50‑day SMA yet the MACD histogram turning negative and RSI hovering in the mid‑50s suggests limited upside momentum. Support sits near $11.84 and resistance near $15.32, placing the current price of $13.92 in a narrow range. Recent price action shows a modest decline from $14.42, while the broader market has been mixed, indicating MARA is underperforming its sector.
Fundamentally, the company reports negative earnings, high debt‑to‑equity (>100%), and negative cash flows, but the forward EPS outlook improves modestly and analysts maintain a “buy” consensus with a median target of $15.5, implying roughly 26% upside potential. High beta (≈3.3) and 30‑day volatility above 75% amplify risk, and the “Extreme Greed” market sentiment may be inflating price expectations despite weak financials.
Fundamentally, the company reports negative earnings, high debt‑to‑equity (>100%), and negative cash flows, but the forward EPS outlook improves modestly and analysts maintain a “buy” consensus with a median target of $15.5, implying roughly 26% upside potential. High beta (≈3.3) and 30‑day volatility above 75% amplify risk, and the “Extreme Greed” market sentiment may be inflating price expectations despite weak financials.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and weakening momentum
- Price near support with limited upside to resistance
- High short‑term volatility and beta
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Analyst price targets suggest modest upside
- Potential recovery in crypto mining revenues
- Continued cash‑flow and debt pressures
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Long‑term growth narrative around Bitcoin mining and AI compute
- Strategic asset acquisitions and diversification of energy assets
- Market sentiment could eventually price in upside if fundamentals improve
Key Metrics & Analysis
Financial Health
Revenue Growth-18.40%
Profit Margin-234.83%
P/E Ratio-16.1
ROE-67.33%
ROA-15.59%
Debt/Equity105.60
P/B Ratio2.4
Op. Cash Flow$-834726016
Free Cash Flow$-531064736
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI53.8
Support$11.84
Resistance$15.32
MA 20$13.86
MA 50$12.54
MA 200$12.55
MACDBearish
VolumeStable
Fear & Greed Index88.5
Valuation
Target Price$17.57
Upside/Downside26.23%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.30
Volatility75.74%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.